Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation

Correction: Mansour Cancer Imaging

10.1186/s40644-024-00708-5

Following publication of the original article [1], we were notified that due to a proofing system error, the author corrections were not submitted. These included mostly typos in the text, as well as the below corrections:

-On page 3, last sentence under Definition of measurable disease, the phrase “Two exemplary cases of MD, which is representative of the overall tumor burden are shown in Fig. 1.” should read “The distribution of MD based on the underlying solid tumor entity is shown in Fig. 1.”

-The caption for Fig. 1 should read “Distribution of measurable based on the underlying tumor entity with highest rate of MD from left to right.” instead of “Distribution of measurable and non-measurable disease based on the underlying tumor entity with highest rate of MD from left to right.”

The original article has been corrected.